Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

